Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38


Standard Operating Procedure for In-house Preparation of (131)I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma.

Pickford MD, Turner JH.

World J Nucl Med. 2012 Sep;11(3):105-9. doi: 10.4103/1450-1147.103408.


Global WARMTH for Patients with Cancer.

Turner JH.

World J Nucl Med. 2012 Sep;11(3):103-4. doi: 10.4103/1450-1147.103407. No abstract available.


Nuclear medicine in Finland.

Kairemo K.

World J Nucl Med. 2012 Sep;11(3):101-2. doi: 10.4103/1450-1147.103406. No abstract available.


When was the Last Time You did Something for the First Time?

Padhy AK.

World J Nucl Med. 2012 Sep;11(3):99-100. doi: 10.4103/1450-1147.103404. No abstract available.


An Incidental Detection of Popliteal Vein Aneurysm during Labeled Leukocyte Scintigraphy.

Hassan HA, Nazri M, Azman RR.

World J Nucl Med. 2012 May;11(2):81-3. doi: 10.4103/1450-1147.103421.


Unilateral breast uptake of tc-99m pertechnetate in a patient with cold nodule of the thyroid.

Gayana S, Bhattacharya A, Kamaleshwaran KK, Mittal BR.

World J Nucl Med. 2012 May;11(2):79-80. doi: 10.4103/1450-1147.103423.


False-negative bone scan and choline pet/ct study in a case of prostate cancer: the pitfall of the small cell prostate carcinoma variant.

Al-Tamimi A, Tan AE, Kwong SY, Sam CC, Chong A, Tan CH.

World J Nucl Med. 2012 May;11(2):75-8. doi: 10.4103/1450-1147.103422.


Monte carlo study of the effect of collimator thickness on T-99m source response in single photon emission computed tomography.

Islamian JP, Toossi MT, Momennezhad M, Zakavi SR, Sadeghi R, Ljungberg M.

World J Nucl Med. 2012 May;11(2):70-4. doi: 10.4103/1450-1147.103419.


(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors.

Desar IM, Gilles R, van Herpen CM, Timmer-Bonte AJ, Cantarini MV, van der Graaf WT, Oyen WJ.

World J Nucl Med. 2012 May;11(2):65-9. doi: 10.4103/1450-1147.103413.


Observed influence of nitroglycerine on myocardial perfusion scintigraphy in patients with multiple vessel coronary artery disease and well-developed collaterals.

Rasulova N, Nazirova L, Akhmedov K, Akhmedova D, Djalalov F, Seydaliev A, Iskandarov F, Kok TY.

World J Nucl Med. 2012 May;11(2):57-64. doi: 10.4103/1450-1147.103410.


(99m)Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: from bench to the bed side.

Choudhury PS, Savio E, Solanki KK, Alonso O, Gupta A, Gambini JP, Doval D, Sharma P, Dondi M.

World J Nucl Med. 2012 May;11(2):47-56. doi: 10.4103/1450-1147.103405.


The density factor: the enigma of dense breast.

Padhy AK, Kok TY, Ng D.

World J Nucl Med. 2012 May;11(2):45-6. doi: 10.4103/1450-1147.103403. No abstract available.


Late Recurrences of Thyroid Carcinoma 24 Years after a Complete Remission: When Monitoring Should be Stopped?

Nwatsock JF, Taïeb D, Zok FD, Mundler O.

World J Nucl Med. 2012 Jan;11(1):42-3. doi: 10.4103/1450-1147.98749.


Mediastinal parathyroid adenoma and brown tumors.

Bernal P, Ucros G, Mejia A.

World J Nucl Med. 2012 Jan;11(1):39-41. doi: 10.4103/1450-1147.98748.


Tako-tsubo syndrome: atypical nuclear medicine findings.

Rodríguez LO, Fernández RG, Luis JJ, González AP.

World J Nucl Med. 2012 Jan;11(1):35-8. doi: 10.4103/1450-1147.98747.


FDG PET/CT in Detection of Metastatic Involvement of Heart and Treatment Monitoring in Non-Hodgkin's Lymphoma.

Agrawal K, Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Varma S.

World J Nucl Med. 2012 Jan;11(1):33-4. doi: 10.4103/1450-1147.98746.


Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline.

Tan CH, Tan EH.

World J Nucl Med. 2012 Jan;11(1):30-2. doi: 10.4103/1450-1147.98745.


A Rare Scenario of Stenosed Type IV Dual LAD with Normal Myocardial Perfusion Scan.

Puranik AD, Nair G, Vijayraghavan RL.

World J Nucl Med. 2012 Jan;11(1):28-9. doi: 10.4103/1450-1147.98744.


Supplemental Content

Loading ...
Support Center